Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field.
Opinion | Here’s What OTC Continuous Glucose Monitors Can Do for Our Patients
Harris is an endocrinologist. About 25 million people stand to gain from the FDA’s recent approval of the first over-the-counter continuous glucose monitor (CGM). That
March 31, 2024